Designing risk-adapted therapy for multiple myeloma: the Mayo perspective.
Lonial
Sagar
S
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D011379:Prognosis; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents